Resumen

RIVALDI MONTENEGRO, Fabiola Beatriz et al. Mortality Risk Factors in Hematological Patients with Pulmonary Aspergillosis at the Medical Clinic Instituto de Prevision Social - Hospital Central. Year 2016 to 2018. Rev. Inst. Med. Trop. [online]. 2021, vol.16, n.2, pp.61-69. ISSN 1996-3696.  https://doi.org/10.18004/imt/2021.16.2.61.

Introduction: It is one of the opportunistic infections with the greatest impact on the patient with hemato-oncological pathologies, its early detection and timely treatment prevents its spread. Objective: To determine risk factors for mortality in hematological patients with pulmonary aspergillosis of patients hospitalized in a medical clinic at the Social Security Institute of the Central Hospital during 2016 to 2018. Methodology: Observational, descriptive, cross-sectional study included patients with hemato-oncological pathologies and infection by aspergillus hospitalized for a period of three years. Results: 55 patients were included, with an average age of 57.2 ± 19.5 years. 36.3% with ages between 40 to 59 years. 52.8% were female. 56.3% presented hypertension. 27.2% non-Hodking lymphoma. 34.5% were in the maintenance phase at the time of pulmonary aspergillosis diagnosis. Regarding the degree of neutropenia, 34.7% presented severe neutropenia. 83.6% were diagnosed through TACAR and galactomannan. Symptom onset time until diagnosis on average days was 12.4 ± 4.7 days. 38.1% presented sputum with positive isolation. Of the antifungal treatment, 78.2% received amphotericin B and 21.8% Voriconazole. In relation to the clinical evolution, 50.9% were high, 25.45% required an intensive care unit, 23.6% obliged. Conclusion: Pulmonary aspergillosis presented with a female predominance, the majority were with severe neutropenia in the phase of chemotherapy maintenance, two thirds were treated with amphotericin B and half were discharged medically.

Palabras clave : Leukemia; Lymphoma; Pulmonary aspergillosis; Voriconazole; Amphotericin B..

        · resumen en Español     · texto en Español     · Español ( pdf )